“Dear Professor Kenyon, I am eleven years old, and, ever since I was six, have developed an acute interest in the study of the extension of human life. I think the research you are doing is amazing. I was wondering if I could meet you to ask some questions about a career in biology?”

SAN FRANCISCO — So began an email from Laura Deming of Auckland, New Zealand, to Cynthia Kenyon, a professor at the University of California, San Francisco. Kenyon had revolutionized aging research with her discovery that a single-gene mutation could double the lifespan of a tiny roundworm called C. elegans. Her finding triggered a hunt for therapies to extend the human lifespan that today is one of the hottest areas in medical research.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy